ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,563Medicare Part D Prescriptions Filled, Including Refills

Rank: 74 out of 783

$825K Total Retail Price of All Prescriptions

Rank: 87 out of 783

459 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 459 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

28% of this provider’s 459 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 9,421 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 658 249 S3 1 2
WARFARIN SODIUM 495 411 2 10
LISINOPRIL 426 317 3 4
FUROSEMIDE 425 250 4 7
GABAPENTIN 419 236 5 15
SIMVASTATIN 395 264 6 3
POTASSIUM CHLORIDE 391 258 7 16
LEVOTHYROXINE SODIUM 388 314 8 1
OMEPRAZOLE 304 193 9 6
METOPROLOL SUCCINATE 246 193 10 13
MELOXICAM 230 171 11 37
AMLODIPINE BESYLATE 213 148 12 5
METFORMIN HCL 205 124 13 8
CITALOPRAM HBR 203 104 14 19
HYDROCHLOROTHIAZIDE 201 172 15 12
DONEPEZIL HCL 193 159 16 24
TRAMADOL HCL 172 113 17 20
LANTUS 167 111 18 38
METOPROLOL TARTRATE 166 126 19 9
POLYETHYLENE GLYCOL 3350 165 144 20 43
CYMBALTA 163 99 21 35
ROPINIROLE HCL 156 113 22 74
ZOLPIDEM TARTRATE 155 85 23 23
FLUOXETINE HCL 151 94 24 45
ADVAIR DISKUS 145 113 25 50
CARVEDILOL 144 107 26 21
TAMSULOSIN HCL 144 88 26 26
CYCLOBENZAPRINE HCL 143 58 R 28 63
LISINOPRIL-HYDROCHLOROTHIAZIDE 141 104 29 33
NOVOLOG 127 74 30 81
ATORVASTATIN CALCIUM 121 66 31 11
SPIRIVA 121 69 31 59
CIPROFLOXACIN HCL 113 66 33 62
FLUTICASONE PROPIONATE 111 66 34 46
ESCITALOPRAM OXALATE 110 51 35 54
TRAZODONE HCL 97 51 36 39
IPRATROPIUM-ALBUTEROL 96 80 37 110
RISPERIDONE 94 54 38 67
NYSTATIN 94 75 38 106
ALENDRONATE SODIUM 90 65 40 25
CLOPIDOGREL 86 76 41 29
ISOSORBIDE MONONITRATE ER 80 52 42 40
NAMENDA 80 69 42 32
OXYBUTYNIN CHLORIDE 79 61 44 96
CRESTOR 79 71 44 27
NEXIUM 79 33 44 28
PROAIR HFA 78 51 47 56
DIOVAN 77 41 48 49
OXYCODONE HCL 77 28 S2 48 123
GEMFIBROZIL 76 54 50 105
MIRTAZAPINE 70 69 51 52
NAPROXEN 67 17 52 104
LYRICA 66 34 53 98
FAMOTIDINE 65 35 54 55
PREDNISONE 65 42 54 36
MORPHINE SULFATE ER 65 19 S2 54 107
RANITIDINE HCL 64 52 57 44
ALLOPURINOL 61 51 58 31
KLOR-CON 10 60 43 59 102
JANUVIA 60 38 59 73
LEVETIRACETAM 59 24 61 89
AMITRIPTYLINE HCL 58 30 R 62 77
PLAVIX 54 42 63 51
SPIRONOLACTONE 52 30 64 57
PANTOPRAZOLE SODIUM 51 32 65 30
FENTANYL 50 21 S2 66 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 18, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.